Let's talk medical research

Amidst the COVID-19 pandemic, finding ways to be innovative with clinical trial patient recruitment has been the name of the game. One trend we’re seeing is the rise of virtual trials, which has made it easier and safer for more people to participate in research. But even if a trial is fully virtual, sample collection may still need to happen to determine eligibility, so one critically important ...

In our work, we’re privileged to meet many patient advocates who are, in their own ways, making life with illness easier for others. Sara Gorman is the owner of a company called Sara Gorman's Pillbags, which creates stylish weekly pill organizers. She has a lupus blog and is the author of Despite Lupus. And, she’s a powerful advocate for the lupus community. We talked to her about her personal ...

Antidote partnered with the BrightFocus Foundation and PatientPoint to survey more than 650 patients living with cognitive disorders and their care partners. We sought to understand patterns of diagnosis as well as reasons patients do or do not take part in clinical research — with the ultimate goal of recognizing opportunities to improve patient engagement around research participation.

Many factors play into running a successful clinical trial. Patient recruitment has an infamous reputation for taking a long time and slowing down the research process. However, with the right patient recruitment strategies, enrolling volunteers doesn’t have to halt your trial’s progress.

A major challenge in clinical trial advertising is being creative within the scope of institutional review board (IRB) and FDA guidelines, as well as distribution channel rules. While it can take more time and research to craft copy within such narrow parameters, it is definitely still possible to engage patients without breaking the rules.

The Hepatitis B Foundation is a national nonprofit organization dedicated to finding a cure and improving the quality of life for those affected by hepatitis B worldwide. We’re proud to partner with them to help people living with hepatitis B find and take part in clinical trials.

When it comes to running a clinical trial, researchers have been getting creative, trading traditional processes for virtual opportunities. This has become especially apparent in light of the COVID-19 pandemic.

Hepatitis B is a liver infection caused by the hepatitis B virus (HBV). For some, hepatitis B can be a short-term illness, but for others, it can become a chronic condition that can lead to serious health issues like cirrhosis or liver cancer. The best way to prevent hepatitis B is by getting vaccinated, which usually occurs shortly after birth.

Ulcerative colitis, a common form of inflammatory bowel disease (IBD), is characterized by continuous inflammation of the colon. There is no known cure for ulcerative colitis and flare-ups may recur. That’s why scientists are actively researching treatments and therapies for people living with ulcerative colitis.

Finding the right people to participate in clinical trials is no easy task, but with the right approach, sponsors can hit the sweet spot in reaching their recruitment goals.